Annexin Pharmaceuticals AB (OSTO:ANNX) Other Financing : kr-0.84 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Annexin Pharmaceuticals AB Other Financing?

Annexin Pharmaceuticals AB's Other Financing for the three months ended in Dec. 2024 was kr0.00 Mil.

Annexin Pharmaceuticals AB's Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.84 Mil.

Annexin Pharmaceuticals AB Other Financing Historical Data

The historical data trend for Annexin Pharmaceuticals AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annexin Pharmaceuticals AB Other Financing Chart

Annexin Pharmaceuticals AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Financing

Get a 7-Day Free Trial

-7.62

-10.29

-0.05

-2.90

0.10

Annexin Pharmaceuticals AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Financing	Get a 7-Day Free Trial															32.73	-	-0.84	-	-

Annexin Pharmaceuticals AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.84 Mil.

Annexin Pharmaceuticals AB Other Financing Related Terms

Thank you for viewing the detailed overview of Annexin Pharmaceuticals AB's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Annexin Pharmaceuticals AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annexin Pharmaceuticals AB (OSTO:ANNX) » Definitions » Other Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kammakargatan 48, Stockholm, SWE, 111 60

Website

https://www.annexinpharma.com

Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.